Real‐world experience of ocrelizumab in multiple sclerosis in a Spanish population

Real‐world experience of ocrelizumab in multiple sclerosis in a Spanish population

Abstract Objective Pivotal trial have shown that patients with multiple sclerosis (MS) receiving ocrelizumab had better outcomes. However, data on ocrelizumab in clinical practice are limited. The aim of this study was to evaluate the preliminary safety profile and effectiveness of ocrelizumab treat...

Full description

Bibliographic Details
Main Authors: Eva Fernandez‐Diaz, Jose A. Perez‐Vicente, Ramon Villaverde‐Gonzalez, Leticia Berenguer‐Ruiz, Antonio Candeliere Merlicco, Maria Luisa Martinez‐Navarro, Julia Gracia Gil, Carlos M. Romero‐Sanchez, Arantxa Alfaro‐Saez, Inmaculada Diaz, Juana Gimenez‐Martinez, Maria Angeles Mendez‐Miralles, Jorge Millan‐Pascual, Javier Jimenez‐Pancho, Santiago Mola, Angel P. Sempere
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.51282

Internet

https://doi.org/10.1002/acn3.51282

Similar Items